A federal judge ordered Michael R. Drobot to appear in person for a hearing to determine whether he should be held in contempt for allegedly

Positive trends including downward loss development, accelerating claim settlement rates, and a drop in both pharmaceutical costs and new lien filings are continuing to drive

The dragnet targeting pharmaceutical manufacturers that pay medical providers to write opioid prescriptions has continued to widen.

Two months after an Insys Therapeutics sales representative pleaded

A federal project that seeks to reconfigure the methods used to get injured and sick employees back to work as soon as possible has taken its

The question of whether platelet-rich plasma is an effective treatment for musculoskeletal injuries is complicated.

PRP, which is prepared from a patient’s own blood, can be